Novel Biomolecule Delivery

DeepCell owns two patents on crystallization of compounds within crystal structures for novel biomolecule delivery. This technology is in an exciting development for edible formulations in human wellness.

DeepCell owns patents as well as brands.

We realized that sometimes the market needs proof-of-concept before adoption.

As a result, we built brands to show how infused active ingredients could be used. We license these patents and brands to operators across North America.